Investigation Overview
May 29, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Amgen, Inc. (NASDAQ:AMGN) shares over potential securities laws violations by Amgen, Inc. and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Amg...
You must register (for free) or login to view the entire investigation.